1.Development of Korean Academy of Medical Sciences Guideline Rating the Physical Impairment; Kidney, Bladder, Urethra, Male and Female Reproductive Systems (Preliminary Report).
Ji Hyeong YU ; Sang Hyun KIM ; Seung Hwan SOHN ; Kyung Hoon PAIK ; Jeong Zoo LEE ; Jang Hwan KIM ; Jong Kwan PARK ; Ki Sung RYU ; Jong Kwan JUN ; Yong Kyoon CHO ; Jae Yong CHUNG
Journal of Korean Medical Science 2009;24(Suppl 2):S277-S287
For the evaluation of the kidney impairment, serum creatinine concentrations or glomerular filtration rates are mainly used, and the conditions of solitary or transplanted kidney and chronic dialysis are also taken into the considerations. Some symptoms and signs of the chronic renal disability in spite of adequate treatment add one additional grade. For evaluating bladder and urethral impairment, the criteria include voiding symptoms and signs. The patients with urinary diversions have impairment grades depending on the alteration of upper urinary tract function. For penile impairment, the degrees are evaluated using the international index of erectile function, nocturnal penile tumescence and color doppler ultrasonography. For evaluating impairment of other male reproductive organs, functional and anatomical changes of these organs, analysis of the semen or hormones and the state of solitary testis are used as the criteria. For evaluating impairment of female reproductive organs, pregnancy potential, requirement of continuous treatment and the ability of sexual intercourse are used. Also, degree of impairment is modified according to the ages in evaluating female reproductive systems. We have tried to make this evaluation system objective, scientific, and convenient, but still find it leaving much to be desired.
*Disability Evaluation
;
Female
;
Genitalia, Female/physiopathology
;
Genitalia, Male/physiopathology
;
Humans
;
Kidney Diseases/classification/*diagnosis
;
Korea
;
Male
;
Program Development
;
Severity of Illness Index
;
Urethral Diseases/classification/*diagnosis
;
Urinary Bladder Diseases/classification/*diagnosis
;
Urologic Diseases/classification/*diagnosis
2.The Prevalence of Depression among Patients with the Top Ten Most Common Cancers in South Korea.
Boram PARK ; Soyoung YOUN ; Ki Kyung YI ; Su yeon LEE ; Jung Sun LEE ; Seockhoon CHUNG
Psychiatry Investigation 2017;14(5):618-625
OBJECTIVE: Among the various psychiatric disorders, depression is a common comorbid condition in cancer patients. Due to the distinct and diverse nature of cancer, the prevalence of depression may be assumed to be affected by differences in primary cancer sites. In this study, we explored the prevalence rates of depression among the ten most prevalent cancers in South Korea using a national patient sample. METHODS: This was a 1-year cross-sectional study using a national patient sample provided by the South Korean National Health Insurance in 2011. We selected all patients who had received ICD-10 codes of the 10 most prevalent cancers and major depressive disorder. Afterwards, the cancer and depression groups were merged and analyzed. RESULTS: The MDD prevalence rate was highest in lung cancer (11.0%), followed by non-Hodgkin's lymphoma (9.2%), prostate (9.1%), bladder (8.8%), breast (7.8%), cervix (7.8%), colorectal (7.7%), stomach (6.9%), liver (6.5%), and thyroid cancer (5.6%). Within all cancer groups, patients with a MDD diagnosis were significantly older (p<0.05) than non-MDD patients. Colorectal, stomach, and thyroid cancer displayed a higher female proportion in the MDD group than the non-MDD group. In the subgroup analysis, the prevalence rate differed by age and sex. CONCLUSION: The prevalence of depression varied according to cancer types. Patients with lung cancer were the most prone to experience depression. Because clinical and psychological factors may influence MDD prevalence, these factors will need to be studied more closely in the future.
Breast
;
Cervix Uteri
;
Cross-Sectional Studies
;
Depression*
;
Depressive Disorder, Major
;
Diagnosis
;
Epidemiology
;
Female
;
Humans
;
International Classification of Diseases
;
Korea*
;
Liver
;
Lung Neoplasms
;
Lymphoma, Non-Hodgkin
;
National Health Programs
;
Prevalence*
;
Prostate
;
Psychology
;
Stomach
;
Thyroid Neoplasms
;
Urinary Bladder